The Atlanta Braves are playing with fire, and it’s not just a spark—it’s a full-blown inferno waiting to ignite. Alex Anthopoulos, the team’s president of baseball operations, is gambling big time with the starting rotation, and the stakes couldn’t be higher. After an offseason filled with promises to add a ‘playoff-caliber starter,’ the Braves have instead lost two potential starters to injury: Spencer Schwellenbach and Hurston Waldrep, both sidelined for months. This leaves the team not just standing still, but actually backtracking in their quest for postseason glory.
But here’s where it gets controversial: despite these setbacks, Anthopoulos has yet to sign a proven starter like Lucas Giolito or Zack Littell. Instead, he’s doubled down on a rotation that’s already a ticking time bomb. Chris Sale, Spencer Strider, Grant Holmes, and Reynaldo López—the current ‘big four’—are far from guarantees of durability. Sale, at 37, is a Cy Young winner but no spring chicken. Holmes has a partially torn UCL, López missed most of last season, and Strider is just two years removed from Tommy John surgery. One more injury, and the Braves’ season could go up in flames faster than a wildfire in July.
And this is the part most people miss: the Braves are still projected to win more games than almost every other team, according to Fangraphs. With superstar Ronald Acuña Jr. under contract for only three more seasons, this should be the time to go all-in for a World Series. So why the hesitation? Why not sign Giolito, who lowered his ERA to 2.51 after adjusting his arm angle, or Littell, who boasts the lowest walk rate among qualified starters? Is Anthopoulos overthinking, or is he simply waiting for prices to drop?
To be fair, the answers aren’t black and white. The Braves’ roster is jammed with pitchers like Bryce Elder and Joey Wentz, who are out of options but still unproven. Elder showed promise late last season, and Wentz’s release extension is elite, but neither is a sure bet. Meanwhile, Anthopoulos’ history suggests he prefers under-the-radar, cost-effective moves—like the Sale acquisition—over splashy signings. But with the team’s luxury tax payroll already among the highest in the league, is this the year to take a leap?
Here’s the kicker: the Braves aren’t alone in their rotation woes. The Phillies, Blue Jays, and others are facing similar challenges. But with Acuña, Austin Riley, and a revamped bullpen, Atlanta’s offense and relief corps could mask some pitching deficiencies—if everything breaks right. But what if it doesn’t?
Anthopoulos’ restrained approach has worked before, earning him seven postseason appearances in eight years. Yet, this feels different. The margin for error is razor-thin, and the consequences of another injury are dire. Is he being cautious, or is he risking it all? Let’s spark a debate: Should the Braves sign a proven starter now, or trust their current group to stay healthy? Voice your thoughts below—this is one conversation you won’t want to miss.
